Meyka Pro banner
Accuray Incorporated

Accuray Incorporated (ARAY) Stock Overview

Explore Accuray Incorporated’s financial performance, market position, analyst ratings, and future outlook.

ARAY●NASDAQ
HealthcareMedical - Devices
$0.30
$0.08(39.38%)
U.S. Market opens in 0h 30m

Accuray Incorporated (ARAY)

Meyka AI Score

Z

Key Financials

Market Cap35.7M
P/E Ratio-0.78
EPS (TTM)$-0.40
ROE-0.99%
Fundamental Analysis

AI Price Forecasts

1 Month$0.26
3 Months$0.01
1 Year Target$0.21

ARAY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Accuray Incorporated (NASDAQ: ARAY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Accuray Incorporated's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ARAY on the NASDAQ shows an RSI of 66.24, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.21 for the NASDAQ listing.

Key metrics behind Accuray Incorporated's NASDAQ-traded stock include a P/E ratio of -0.78 and a market capitalization of 35.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ARAY on the NASDAQ.

Price Performance (NASDAQ: ARAY)

1-Day Change
39.38%
5-Day Change
26.60%
1-Month Change
9.46%
3-Month Change
13.30%
6-Month Change
-24.22%
Year-to-Date (YTD) Change
-63.64%
1-Year Change
-81.61%
3-Year Change
-89.02%
5-Year Change
-92.43%
All-Time (Max) Change
-98.95%

Contact Information

608 824 2800
1240 Deming Way, Madison, WI, 53717-1954

Company Facts

8,090 Employees
IPO DateFeb 8, 2007
CountryUS
Actively Trading

Frequently Asked Questions